Go Pro

Edwards Lifesciences (EW) Short Interest Ratio & Short Volume

Edwards Lifesciences logo
$92.01 +2.29 (+2.55%)
Closing price 08/10/2026 03:58 PM Eastern
Extended Trading
$91.92 -0.09 (-0.10%)
As of 04:01 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Edwards Lifesciences Short Interest Overview

As of July 15, 2026, Edwards Lifesciences (EW) had a short interest of 11.35 million shares sold short, representing 1.98% of the public float. This marks a -1.00% decrease in short interest since the prior report. The short interest ratio (days to cover) is 2.5, meaning it would take 2.5 days of the average trading volume of 5.10 million shares to cover all short positions.

Current Short Interest
11,352,019 shares
Previous Short Interest
11,466,764 shares
Change Vs. Previous Month
-1.00%
Dollar Volume Sold Short
$990.13 million
Short Interest Ratio
2.5 Days to Cover
Last Record Date
July 15, 2026
Outstanding Shares
575,800,000 shares
Short Percent of Float
1.98%
Today's Trading Volume
4,443,902 shares
Average Trading Volume
5,097,141 shares
Today's Volume Vs. Average
87%
Short Selling Edwards Lifesciences?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Edwards Lifesciences and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History

EW Short Interest Over Time

EW Days to Cover Over Time

EW Percentage of Float Shorted Over Time

Edwards Lifesciences Tesla Short Interest History & Recent Changes

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/15/202611,352,019 shares $990.13 million -1.0%2.0%2.51 $87.22
6/30/202611,466,764 shares $1.04 billion -2.8%2.0%2.11 $90.47
6/15/202611,797,466 shares $1.02 billion -3.0%2.1%2.4 $86.27
5/29/202612,163,159 shares $1.05 billion +6.8%2.1%2.32 $86.41
5/15/202611,394,337 shares $926.85 million +8.1%2.0%2.54 $81.34
4/30/202610,538,452 shares $880.51 million +12.9%1.8%1.66 $83.55
4/15/20269,331,359 shares $729.36 million -6.4%1.6%1.97 $78.16
3/31/20269,971,356 shares $798.37 million -8.9%1.7%2.27 $80.07
3/13/202610,945,893 shares $895.63 million -11.6%1.9%2.16 $81.82
2/27/202612,376,285 shares $1.07 billion +56.6%2.2%2.68 $86.47
2/13/20267,902,820 shares $599.03 million -2.4%1.4%1.28 $75.80
1/30/20268,093,410 shares $657.86 million +2.2%1.4%2.31 $81.28
1/15/20267,916,291 shares $667.64 million +10.9%1.4%2.06 $84.34
12/31/20257,138,485 shares $608.63 million +26.6%1.2%2.56 $85.26
12/15/20255,640,466 shares $470.48 million -19.2%1.0%1.87 $83.41
11/28/20256,980,005 shares $605.45 million -28.6%1.2%1.82 $86.74
11/14/20259,771,913 shares $843.81 million +7.2%1.7%2.61 $86.35
10/31/20259,116,391 shares $751.90 million +17.1%1.6%1.46 $82.48
10/15/20257,790,000 shares $568.07 million +4.4%1.4%1.8 $72.92
9/30/20257,460,000 shares $580.66 million +2.8%1.3%1.7 $77.84
9/15/20257,260,000 shares $552.49 million -29.9%1.3%1.7 $76.10
8/31/202510,350,000 shares $843.29 million +27.2%1.8%2.5 $81.48
8/15/20258,140,000 shares $637.04 million +1.8%1.4%1.9 $78.26
7/31/20258,000,000 shares $634.48 million +15.8%1.4%1.8 $79.31
7/15/20256,910,000 shares $531.34 million -4.2%1.2%1.6 $76.90
6/30/20257,210,000 shares $564.83 million +18.8%1.3%1.7 $78.34
6/15/20256,070,000 shares $455.97 million +3.9%1.1%1.3 $75.12
5/31/20255,840,000 shares $456.05 million -20.9%1.0%1.2 $78.09
5/15/20257,380,000 shares $566.71 million -10.4%1.3%1.5 $76.79
4/30/20258,240,000 shares $622.12 million +3.9%1.4%1.8 $75.50
4/15/20257,930,000 shares $560.13 million -16.9%1.4%1.6 $70.63
3/31/20259,540,000 shares $692.25 million +1.0%1.7%2 $72.56
3/15/20259,450,000 shares $655.52 million +11.3%1.6%2 $69.37
2/28/20258,490,000 shares $607.97 million -28.7%1.5%1.8 $71.61
2/15/202511,900,000 shares $907.08 million +18.4%2.1%2.5 $76.23
1/31/202510,050,000 shares $727.69 million +11.2%1.7%2.1 $72.41
1/15/20259,040,000 shares $635.42 million -20.1%1.6%1.8 $70.29
12/31/202411,310,000 shares $837.28 million +54.9%2.0%2.2 $74.03
12/15/20247,300,000 shares $535.24 million -14.9%1.3%1.3 $73.32
11/30/20248,580,000 shares $612.18 million +24.9%1.5%1.5 $71.35
Your book attached (Ad)

Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.tc pixel

Download the Safe Trade Options Formula book for free before access closes
11/15/20246,870,000 shares $465.51 million -10.8%1.2%1.1 $67.76
10/31/20247,700,000 shares $516.05 million -6.3%1.3%1.3 $67.02
10/15/20248,220,000 shares $566.36 million -14.5%1.4%1.2 $68.90
9/30/20249,610,000 shares $634.16 million -15.6%1.6%1.4 $65.99
9/15/202411,380,000 shares $779.76 million +81.8%1.9%1.8 $68.52
8/31/20246,260,000 shares $437.95 million -1.3%1.1%1.1 $69.96
8/15/20246,340,000 shares $432.01 million +3.9%1.1%1.3 $68.14
7/31/20246,100,000 shares $384.54 million -20.8%1.0%1.4 $63.04
7/15/20247,700,000 shares $689.15 million -15.8%1.3%2.7 $89.50
6/30/20249,140,000 shares $844.26 million +11.6%1.5%3.3 $92.37
6/15/20248,190,000 shares $714.91 million -1.2%1.4%3 $87.29
5/31/20248,290,000 shares $720.94 million +3.6%1.4%2.9 $86.97
5/15/20248,000,000 shares $721.28 million -16.9%1.4%2.5 $90.16
4/30/20249,630,000 shares $815.47 million +30.5%1.6%2.7 $84.68
4/15/20247,380,000 shares $658.30 million -28.9%1.3%1.9 $89.20
3/31/202410,380,000 shares $991.91 million -0.7%1.8%2.6 $95.56
3/15/202410,450,000 shares $964.64 million +23.8%1.8%2.7 $92.31
2/29/20248,440,000 shares $716.30 million -16.4%1.4%1.9 $84.87
2/15/202410,090,000 shares $868.35 million +1.3%1.7%2.3 $86.06
1/31/20249,960,000 shares $781.56 million -8.4%1.7%2.2 $78.47
1/15/202410,870,000 shares $804.71 million +2.0%1.8%2.4 $74.03
12/31/202310,660,000 shares $812.83 million -21.3%1.8%2.3 $76.25
12/15/202313,540,000 shares $1.04 billion +34.7%2.3%2.8 $76.90
11/30/202310,050,000 shares $680.49 million -6.5%1.7%2.3 $67.71
11/15/202310,750,000 shares $720.36 million -6.3%1.8%2.6 $67.01
10/31/202311,470,000 shares $730.87 million -1.1%1.9%2.9 $63.72
10/15/202311,600,000 shares $821.05 million -13.4%1.9%3.1 $70.78
9/30/202313,400,000 shares $928.35 million +5.5%2.2%3.8 $69.28
9/15/202312,700,000 shares $929.64 million +18.1%2.1%4 $73.20
8/31/202310,750,000 shares $822.05 million +13.0%1.8%3.4 $76.47
8/15/20239,510,000 shares $759.47 million +0.4%1.6%3 $79.86
7/31/20239,470,000 shares $777.20 million -2.9%1.6%3.3 $82.07
7/15/20239,750,000 shares $910.46 million -0.9%1.6%3.7 $93.38
6/30/20239,840,000 shares $928.21 million -4.4%1.6%3.7 $94.33
6/15/202310,290,000 shares $939.37 million -7.4%1.7%3.8 $91.29
5/31/202311,110,000 shares $935.91 million +12.9%1.9%3.9 $84.24
5/15/20239,840,000 shares $874.97 million +7.2%1.6%3.2 $88.92
4/30/20239,180,000 shares $807.66 million -27.3%1.5%2.8 $87.98
4/15/202312,620,000 shares $1.06 billion -10.1%2.1%3.6 $84.36
3/31/202314,040,000 shares $1.16 billion -17.1%2.3%4.1 $82.73
3/15/202316,940,000 shares $1.35 billion +32.7%2.8%4.7 $79.48
2/28/202312,770,000 shares $1.03 billion +6.8%2.1%3.2 $80.44
2/15/202311,960,000 shares $931.92 million -12.4%2.0%3 $77.92
1/31/202313,650,000 shares $1.05 billion -2.0%2.2%3 $76.70
1/15/202313,930,000 shares $1.09 billion -9.2%2.3%2.7 $78.31
12/30/202215,340,000 shares $1.14 billion +9.9%2.5%3 $74.61
12/15/202213,960,000 shares $1.03 billion +27.0%2.3%2.8 $73.55
11/30/202210,990,000 shares $848.98 million +4.0%1.8%2.3 $77.25
11/15/202210,570,000 shares $802.90 million +30.3%1.7%2.5 $75.96
10/31/20228,110,000 shares $587.41 million +8.9%1.3%2.2 $72.43
The end may be near for these iconic stocks (Ad)

Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are triggering a historic wealth transfer already underway in 2026. Household names like Intuit (-57%), Boston Scientific (-49%), and Tractor Supply (-40%) are cratering, while lesser-known companies like Sandisk (+573%) and Rackspace (+444%) surge. Chaikin has identified specific stocks he believes investors should sell before they fall further - and the names may surprise you. He's also pinpointing a company tapped as Nvidia's self-driving partner and a potential AI megadeal that could split into three high-growth stocks. Stream his free presentation to get every buy and sell recommendation with no membership or credit card required.tc pixel

Watch Marc Chaikin's free presentation and get his full buy-and-sell list today
10/15/20227,450,000 shares $614.03 million -1.7%1.2%2.7 $82.42
9/30/20227,580,000 shares $626.34 million +15.9%1.2%3 $82.63
9/15/20226,540,000 shares $620.52 million +77.7%1.1%2.5 $94.88
8/31/20223,680,000 shares $331.57 million -27.0%0.6%1.4 $90.10
8/15/20225,040,000 shares $527.89 million -9.0%0.8%2 $104.74
7/31/20225,540,000 shares $556.99 million -16.8%0.9%2.1 $100.54
7/15/20226,660,000 shares $662.20 million +7.3%1.1%2.4 $99.43
6/30/20226,210,000 shares $590.51 million +5.8%1.0%2.2 $95.09
6/15/20225,870,000 shares $521.14 million -10.5%2.9%2 $88.78
5/31/20226,560,000 shares $661.58 million +27.4%1.1%2.3 $100.85
5/15/20225,150,000 shares $502.38 million +6.0%0.8%1.9 $97.55
4/30/20224,860,000 shares $514.09 million -15.2%0.8%1.8 $105.78
4/15/20225,730,000 shares $687.71 million +28.5%0.9%2.1 $120.02
3/31/20224,460,000 shares $525.03 million No Change0.7%1.7 $117.72
3/15/20224,460,000 shares $473.43 million -20.6%0.7%1.7 $106.15
2/28/20225,620,000 shares $631.52 million -11.1%0.9%2.1 $112.37
2/15/20226,320,000 shares $701.08 million +9.5%1.0%2.3 $110.93
1/31/20225,770,000 shares $630.08 million +6.5%0.9%2.2 $109.20
1/15/20225,420,000 shares $640.97 million -10.9%0.9%2.2 $118.26
12/31/20216,080,000 shares $787.66 million +10.0%1.0%2.6 $129.55
12/15/20215,530,000 shares $663.10 million -3.8%0.9%2.2 $119.91
11/30/20215,750,000 shares $617.03 million +4.0%0.9%2.5 $107.31
11/15/20215,530,000 shares $645.30 million -20.2%0.9%2.6 $116.69
10/29/20216,930,000 shares $830.35 million +6.0%1.1%3.3 $119.82
10/15/20216,540,000 shares $733.53 million +7.6%1.1%3.2 $112.16
9/30/20216,080,000 shares $688.32 million +2.7%1.0%2.8 $113.21
9/15/20215,920,000 shares $716.44 million -2.0%1.0%2.8 $121.02
8/31/20216,040,000 shares $707.77 million +0.8%1.0%2.8 $117.18
8/13/20215,990,000 shares $677.77 million -1.3%1.0%2.6 $113.15

EW Short Interest - Frequently Asked Questions

Short interest is the volume of Edwards Lifesciences shares that have been sold short but have not yet been covered or closed out. As of July 15th, investors have sold 11,352,019 shares of EW short. 1.98% of Edwards Lifesciences' shares are currently sold short. Learn More on Edwards Lifesciences' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EW shares currently have a short interest ratio of 2.5. Learn More on Edwards Lifesciences's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.98% of Edwards Lifesciences' floating shares are currently sold short.

Edwards Lifesciences saw a decrease in short interest in July. As of July 15th, there was short interest totaling 11,352,019 shares, a decrease of 1.0% from the previous total of 11,466,764 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

1.98% of Edwards Lifesciences' shares are currently sold short. Here is how the short interest of companies in the sector of "healthcare" compare to Edwards Lifesciences: Henry Schein, Inc. (5.79%), AMN Healthcare Services Inc (9.42%), Abbott Laboratories (1.43%), Stryker Corporation (1.92%), Intuitive Surgical, Inc. (1.91%), Medtronic PLC (1.49%), Boston Scientific Corporation (1.91%), Becton, Dickinson and Company (3.78%), IDEXX Laboratories, Inc. (2.68%), DexCom, Inc. (4.85%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($73.09 billion), Invesco QQQ ($48.11 billion), iShares Russell 2000 ETF ($23.61 billion), Sandisk Corporation ($12.69 billion), Nebius Group N.V. ($12.18 billion), Western Digital Corporation ($11.95 billion), SPDR S&P Biotech ETF ($11.73 billion), Quhuo Limited Sponsored ADR ($9.74 billion), VanEck Semiconductor ETF ($9.57 billion), and Financial Select Sector SPDR Fund ($8.43 billion). View all of the most shorted stocks.

Short selling EW is an investing strategy that aims to generate trading profit from Edwards Lifesciences as its price is falling. EW shares are trading up $2.29 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Edwards Lifesciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of EW, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EW, twice per month. The most recent reporting period available is July, 15 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like EW:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.



Short interest data for NYSE:EW is sourced from the Financial Industry Regulatory Authority (FINRA), with the most recent report published on 7/24/2026. FINRA publishes updated short interest twice a month.
From Our Partners